Sun Y - Search Results

1

RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.

Xu Y, Fang F, Sun Y, St Clair DK, St Clair WH. Xu Y, et al. Among authors: sun y. Mol Cancer Ther. 2010 Apr;9(4):803-12. doi: 10.1158/1535-7163.MCT-09-1001. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371728 Free PMC article.

2

The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.

Sun Y, St Clair DK, Fang F, Warren GW, Rangnekar VM, Crooks PA, St Clair WH. Sun Y, et al. Mol Cancer Ther. 2007 Sep;6(9):2477-86. doi: 10.1158/1535-7163.MCT-07-0186. Mol Cancer Ther. 2007. PMID: 17876045 Free PMC article.

3

RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.

Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, Sun Y, Bakthavatchalu V, Muthuswamy A, St Clair WH. Xu Y, et al. Among authors: sun y. Cancer Res. 2009 Apr 15;69(8):3267-71. doi: 10.1158/0008-5472.CAN-08-4635. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351823 Free PMC article.

4

A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells.

Sun Y, St Clair DK, Xu Y, Crooks PA, St Clair WH. Sun Y, et al. Cancer Res. 2010 Apr 1;70(7):2880-90. doi: 10.1158/0008-5472.CAN-09-4572. Epub 2010 Mar 16. Cancer Res. 2010. PMID: 20233868 Free PMC article.

5

p53 regulation of energy metabolism and mitochondria regulation of p53 in cancer cells: an insight into the role of manganese superoxide dismutase.

Sun Y, Holley AK, St Clair DK. Sun Y, et al. Curr Pharm Biotechnol. 2013;14(3):261-73. doi: 10.2174/1389201011314030003. Curr Pharm Biotechnol. 2013. PMID: 22201594 Review.

6

Peptide-Based Complex Coacervates Stabilized by Cation-π Interactions for Cell Engineering.

Sun Y, Wu X, Li J, Verma CS, Yu J, Miserez A. Sun Y, et al. J Am Chem Soc. 2025 Jan 26. doi: 10.1021/jacs.4c14469. Online ahead of print. J Am Chem Soc. 2025. PMID: 39864072

7

A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.

Wei CJ, Tang Y, Sun YB, Yang TL, Yan C, Liu H, Liu J, Huang JN, Wang MH, Yao ZW, Yang JL, Wang ZC, Li QF. Wei CJ, et al. Among authors: sun yb. NPJ Digit Med. 2025 Jan 26;8(1):56. doi: 10.1038/s41746-025-01454-z. NPJ Digit Med. 2025. PMID: 39863790 Free article.

8

[CIC::NUTM1 sarcoma: a clinicopathological analysis of two cases].

Zhao LN, Yuan JP, He HH, Yan HL, Sun YY. Zhao LN, et al. Among authors: sun yy. Zhonghua Bing Li Xue Za Zhi. 2025 Feb 8;54(2):165-167. doi: 10.3760/cma.j.cn112151-20240930-00652. Zhonghua Bing Li Xue Za Zhi. 2025. PMID: 39863533 Chinese.

9

Prognostic Value of Dynamic Measurable Residual Disease Monitoring by Multiflowcytometry in Elderly Patients With Nonintensively Treated Acute Myeloid Leukemia.

Sun Y, Han X, Zhang Y, Fu W, Fang Y, Liu J, Xu L, Wang T, Zhong H. Sun Y, et al. Clin Lymphoma Myeloma Leuk. 2025 Jan 2:S2152-2650(24)02470-4. doi: 10.1016/j.clml.2024.12.020. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2025. PMID: 39863462

10

Corrigendum to "Efficacy and safety of anti-CD19 CAR-T in a mouse model of IgG4-related disease" [Int. Immunopharmacol. 145 (2025) 113779].

Sun Y, Huang S, Zhang B, Peng Y, Lu H, Jia Y, Sun R, Zhang F, Zhou J, Peng L, Li M, Zhang W, Fei Y. Sun Y, et al. Int Immunopharmacol. 2025 Jan 24:114125. doi: 10.1016/j.intimp.2025.114125. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39863434 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,828 results

Search Page

Filters